BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Treatment
31 results:

  • 1. Prognostic and predictive biomarkers in paediatric solid tumours.
    Glembocki AI; Somers GR
    Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic and Molecular Characteristics of Ovarian Carcinosarcoma.
    Ramphal K; Hadfield MJ; Bandera CM; Hart J; Dizon DS
    Am J Clin Oncol; 2023 Dec; 46(12):572-576. PubMed ID: 37986208
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis.
    Hu J; Hameed MR; Agaram NP; Whiting KA; Qin LX; Villano AM; O'Connor RB; Rozenberg JM; Cohen S; Prendergast K; Kryeziu S; White RL; Posner MC; Socci ND; Gounder MM; Singer S; Crago AM
    Clin Cancer Res; 2024 Jan; 30(2):450-461. PubMed ID: 37943631
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors.
    Douglass DP; Navid F; Weiss AR
    Paediatr Drugs; 2022 Sep; 24(5):433-445. PubMed ID: 35902507
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Congenital Teratocarcinosarcoma With
    Almarzooqi S; Reyes-Múgica M; Ali BR; Habbal A; Asha MJ; AlShamsi ET
    Pediatr Dev Pathol; 2022; 25(5):562-567. PubMed ID: 35732187
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR).
    Benech N; Bonvalot S; Dufresne A; Gangi A; Le Péchoux C; Lopez-Trabada-Ataz D; Meurgey A; Nicolas N; Orbach D; Penel N; Salas S; Saurin JC; Walter T; Lecomte T; Bouché O; ; ; ; ; ; ; ; ; ;
    Dig Liver Dis; 2022 Jun; 54(6):737-746. PubMed ID: 35508462
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy.
    Campbell KM; Thaker M; Medina E; Kalbasi A; Singh A; Ribas A; Nowicki TS
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35264439
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A Prospective Observational Study of Active Surveillance in Primary Desmoid Fibromatosis.
    Colombo C; Fiore M; Grignani G; Tolomeo F; Merlini A; Palassini E; Collini P; Stacchiotti S; Casali PG; Perrone F; Mariani L; Gronchi A
    Clin Cancer Res; 2022 Sep; 28(18):4027-4032. PubMed ID: 35247923
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in ctnnb1 or APC: A Multi-institutional Retrospective Study.
    Nathenson MJ; Hu J; Ratan R; Somaiah N; Hsu R; DeMaria PJ; Catoe HW; Pang A; Subhawong TK; Amini B; Sweet K; Feister K; Malik K; Jagannathan J; Braschi-Amirfarzan M; Sheren J; Caldas Y; Moreno Tellez C; Rosenberg AE; Lazar AJ; Maki RG; Benedetto P; Cohen J; Trent JC; Ravi V; Patel S; Wilky BA
    Clin Cancer Res; 2022 Sep; 28(18):4092-4104. PubMed ID: 35180772
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Desmoid fibromatosis: is the current picture changing?
    Pandrowala S; Jones RL; Gupta S; Gulia A
    Future Oncol; 2021 Sep; 17(25):3397-3408. PubMed ID: 34227399
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Desmoid tumors: diagnostic and therapeutic considerations.
    Brener-Chaoul M; Cervantes-Gutiérrez Ó; Padilla-Longoria R; Martín-Téllez KS
    Gac Med Mex; 2020; 156(5):439-445. PubMed ID: 33372933
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Desmoid tumors: To treat or not to treat, That is the question.
    Kasper B; Raut CP; Gronchi A
    Cancer; 2020 Dec; 126(24):5213-5221. PubMed ID: 33022074
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PIK3CA somatic mutation in sinonasal teratocarcinosarcoma.
    Belardinilli F; De Vincentiis L; D'Ecclesia A; Giannini G; Giangaspero F; Corsi A
    Auris Nasus Larynx; 2021 Jun; 48(3):530-534. PubMed ID: 32389511
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas.
    Yao X; Ghert M; Dickson BC; Popovic S; Purgina BM; Verma S; Werier J; Kandel RA
    Cancer Treat Rev; 2020 Apr; 85():101987. PubMed ID: 32092619
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients.
    Desmoid Tumor Working Group
    Eur J Cancer; 2020 Mar; 127():96-107. PubMed ID: 32004793
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86).
    Dhani NC; Hirte HW; Wang L; Burnier JV; Jain A; Butler MO; Welch S; Fleming GF; Hurteau J; Matsuo K; Matei D; Jimenez W; Johnston C; Cristea M; Tonkin K; Ghatage P; Lheureux S; Mehta A; Quintos J; Tan Q; Kamel-Reid S; Ludkovski O; Tsao MS; Wright JJ; Oza AM
    Clin Cancer Res; 2020 Jun; 26(11):2477-2486. PubMed ID: 31992589
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Breast desmoid tumor management in France: toward a new strategy.
    Duazo-Cassin L; Le Guellec S; Lusque A; Chantalat E; Laé M; Terrier P; Coindre JM; Boulet B; Le Boulc'h M; Gangloff D; Meresse T; Chaput B; Al Ali A; Rimareix F; Bonvalot S; Vaysse C
    Breast Cancer Res Treat; 2019 Jul; 176(2):329-335. PubMed ID: 31016642
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas.
    Liu Y; Weber Z; San Lucas FA; Deshpande A; Jakubek YA; Sulaiman R; Fagerness M; Flier N; Sulaiman J; Davis CM; Fowler J; Starks D; Rojas-Espaillat L; Lazar AJ; Davies GE; Ehli EA; Scheet P
    Gynecol Oncol; 2018 Nov; 151(2):243-249. PubMed ID: 30194005
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Interaction of molecular alterations with immune response in melanoma.
    Szczepaniak Sloane RA; Gopalakrishnan V; Reddy SM; Zhang X; Reuben A; Wargo JA
    Cancer; 2017 Jun; 123(S11):2130-2142. PubMed ID: 28543700
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Desmoid-Type Fibromatosis: Who, When, and How to Treat.
    Martínez Trufero J; Pajares Bernad I; Torres Ramón I; Hernando Cubero J; Pazo Cid R
    Curr Treat Options Oncol; 2017 May; 18(5):29. PubMed ID: 28439797
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.